GreenLight Biosciences Merger $2M Securities Settlement

GreenLight Biosciences Merger $2M Securities Settlement

This settlement is closed. The claim deadline has passed and new claims are no longer being accepted. This page is kept for reference — see settlements that are still open →

By the Class Action Buddy Editorial Team · Last reviewed July 22, 2026

See details
Max Payout
Jul 29, 2026
Filing Deadline
Yes
Proof Required?
A $2 million class action settlement has been reached involving GreenLight Biosciences and its merger transaction. The lawsuit alleges that investors were harmed in connection with the merger — typically these types of securities cases involve claims that shareholders weren't given complete or accurate information before being asked to vote on or accept a merger deal. If you owned shares of GreenLight Biosciences stock during the relevant period surrounding the merger, you may be entitled to a portion of this settlement fund. Securities settlements like this one are designed to compensate investors who may have suffered losses or been disadvantaged as a result of how the merger was handled. The claims deadline is July 29, 2026, so there's time to get your paperwork in order — but it's worth starting the process sooner rather than later. Class Action Buddy can help you understand if you qualify and walk you through filing your claim.
🎯

Looking for a settlement you can still file?

This one is closed, but our 60-second eligibility quiz finds the ones that are still open.

Check Eligibility →

Who Was Eligible?

Who the settlement covered:

  • You purchased or held shares of GreenLight Biosciences (ticker: GNLB) during the relevant class period related to the merger transaction
  • You were a shareholder of record or beneficial owner at a qualifying date tied to the merger
  • You are a U.S. resident or otherwise eligible investor who held GreenLight Biosciences securities during the covered period
  • You did not opt out of the settlement class
  • Note: Specific class period dates and full eligibility details are available on the official settlement website at rg2claims.com

How Much Did It Pay?

The total settlement fund is $2 million, which will be distributed among eligible shareholders after deducting legal fees, administrative costs, and other approved expenses. The actual amount each claimant receives will depend on factors like how many shares you owned, when you held them, and how many valid claims are submitted in total. Because the exact payout per share or per claimant has not been publicly specified, individual recoveries may vary. In securities settlements of this size, payouts are often modest on a per-share basis, but every dollar counts — and filing a claim costs you nothing to try. Full details on the distribution plan should be available through the official settlement administrator at rg2claims.com.

How this claim was filed

This settlement is closed, so the steps below are kept for reference only — they no longer lead anywhere you can file.

  • Check your eligibility: Confirm you owned GreenLight Biosciences shares during the qualifying period by reviewing your brokerage statements or trade confirmations
  • Gather your proof: Locate documentation showing your share ownership, such as brokerage account statements, trade confirmations, or a letter from your broker — proof of ownership is required for this settlement
  • Visit the official claim site: Go to rg2claims.com to access the official claim form for this settlement
  • Complete and submit your claim form: Fill out the required information accurately, attach your supporting documents, and submit before the July 29, 2026 deadline
  • Keep a copy: Save a copy of your submitted claim form and any confirmation you receive for your records

Looking for something you can still claim?

This one has closed, but the open settlements list is kept current, and Class Action Buddy will tell you when a new one matches your profile.

Frequently Asked Questions

What is the deadline to file a claim for the GreenLight Biosciences Merger $2M Securities Settlement?

The deadline to file a claim was Jul 29, 2026, and it has passed. Claims are no longer accepted for this settlement.

Did I need documentation for the GreenLight Biosciences Merger $2M Securities Settlement?

Yes — this settlement required supporting documentation, and the official claim form set out what counted.

What is the GreenLight Biosciences merger securities settlement about?

This is a $2 million class action settlement related to GreenLight Biosciences and its merger. The lawsuit typically involves allegations that shareholders were not provided complete or accurate information in connection with the merger process. The settlement resolves these claims without the company admitting any wrongdoing.

Do I need proof to file a claim in the GreenLight Biosciences settlement?

Yes, proof is required. You will likely need to provide documentation showing that you owned GreenLight Biosciences shares during the relevant period — such as brokerage statements or trade confirmations. Make sure to gather these documents before submitting your claim.

What is the deadline to file a claim for the GreenLight Biosciences settlement?

The claims filing deadline is July 29, 2026. It's a good idea to file as early as possible to avoid missing out, especially if you need time to track down brokerage records or other proof of share ownership.

Primary source: official settlement administrator — rg2claims.com. The settlement details on this page were checked against the administrator’s official website.

Class Action Buddy is an independent directory and is not affiliated with, endorsed by, or sponsored by the settlement administrator or the court. This page is general information, not legal advice. See how we verify settlements.

This settlement has closed

The filing deadline for this one has passed, so no new claims are being accepted. Class Action Buddy tracks the settlements that are still open and tells you when a new one matches your profile.

See settlements that are open →